Sinusite fongique allergique et aspergillose bronchopulmonaire allergique: Association fortuite ou entité nosologique rhinobronchique?Allergic fungal sinusitis. L’aspergillose cutanée est une infection rare de la peau par un champignon du genre pulmonaires chez l’humain. On en distingue plusieurs types: aspergillose bronchopulmonaire allergique, aspergillose invasive et aspergillome. Request PDF on ResearchGate | Aspergillose bronchopulmonaire allergique: évaluation d’un traitement d’entretien par Ambisome ® nébulisé | Background.

Author: JoJohn Gushakar
Country: Burundi
Language: English (Spanish)
Genre: Technology
Published (Last): 16 May 2012
Pages: 24
PDF File Size: 11.97 Mb
ePub File Size: 8.50 Mb
ISBN: 776-7-22638-582-1
Downloads: 86690
Price: Free* [*Free Regsitration Required]
Uploader: Kagakazahn

Treatment involves systemic corticosteroids and itraconazole.


If you want to subscribe to this journal, see our rates You can purchase this item in Pay Per View: When the diagnosis is established on the basis of these criteria, two types have been identified: The interests of a therapeutic strategy using nebulized liposomal amphotericin B LAmB are to heighten antifungal lung tissue concentration, to circumvent drug interactions and decrease the potential toxicity of systemic antifungal treatments.

Aspergillus Website Newsletters Our most recent newsletters since August can be found here. If you are a subscriber, please sign in ‘My Account’ at the top right of the screen. Subscribe to Newsletter Fill out your e-mail address to receive our newsletter! Our most recent bronchoulmonaire since August can be found here.

Outline Masquer le plan. Create new account Request new password.


Personal information regarding our website’s visitors, including their identity, is confidential. Recommendations regarding dosage and duration of treatment are not very precise. The results will guide practitioners in the management of ABPA bronchopu,monaire and help to define the place of aerosols of LAmB on “evidence base medicine” criteria.

Aspergillose bronchopulmonaire allergique Allergic bronchopulmonary aspergillosis. The currently used combination of itraconazole and corticosteroid therapy has many limitations.

ABPA prognosis is directly associated with exacerbation control and the main objective of the treatment is to decrease their frequency and duration. Journal page Archives Contents list. Top of the page – Article Outline.

Aspergillose bronchopulmonaire allergique – EM|consulte

This is a phase II, multicentre, randomized, single blind, controlled therapeutic study, with the objective of comparing the potential benefit on exacerbation control of a maintenance therapy by LAmB nebulization.

Contact Help Who are we? This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Finally, this association leads to improved eradication of Aspergillus, thereby limiting the risk of side effects and the emergence of treatment-resistant Aspergillus strains. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.

As per the Law relating to information storage and personal integrity, you have the right to oppose art 26 of that lawaccess art 34 of that law and rectify art 36 of that law your personal data.


Its natural history includes possibly life-threatening exacerbations and evolution towards fixed obstructive ventilatory disorders or even irreversible lung fibrosis lesions. If you want to return to Veterinary articles please click here. Fill out your e-mail address to receive our newsletter! Access to the PDF text.

Skip to main content. Several studies suggest a beneficial role for omalizumab, but only placebo-controlled studies will clarify its indication in ABPA.

You can move this window by clicking on the headline. Aspergillose bronchopulmonaire, Asthme, AspergillusAllergie, Mucoviscidose. An archive of our older newsletters dating back to can be found here.

The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and allerigque to disclose this data to third parties. Access to the full text of this article requires a subscription. Access to the text HTML. The main objective of the study is to compare the incidence of severe clinical exacerbations in ABPA treatment, between a maintenance treatment strategy with nebulized LAmB and a conventional strategy without antifungal maintenance therapy.